New research signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.
from
https://healthnews010.wordpress.com/2019/10/17/pioneering-cell-therapies-for-non-responders-to-current-immunotherapies/
No comments:
Post a Comment